JAN 12, 2016 4:51 AM PST

Brain Game Company Fined For False Claims

Games and smartphone apps that claim to “train your brain” and stave off dementia, memory loss and other neurological declines have been around for years. With the Baby Boomer generation now in their 60’s and 70’s, these high tech games are popular. No one wants to think about getting older and losing cognitive abilities. One company however has found itself the subject of a complaint from the Federal Trade Commission who filed charges that their product was not as advertised.
No evidence that Luminosity games actually improve brain function
 Lumos Labs, makers of the Lumosity “brain training” program of games and electronic puzzles have agreed to settle Federal Trade Commission charges alleging that they deceived consumers with unfounded claims. Luminosity ads claimed that using their system would result in less age related memory loss, ward off dementia and even give users better performance levels at work or school. The problem is that the company couldn’t back any of those claims up with scientific evidence or peer-reviewed brain research.

The company and its founder Kumal Sarkar have agreed to pay $2m million in fines. They also must notify all subscribers of the action taken by the FTC and provide them with instructions on how to cancel auto-renewal plans so they will not continue to be billed.

“Lumosity preyed on consumers’ fears about age-related cognitive decline, suggesting their games could stave off memory loss, dementia, and even Alzheimer’s disease,” said Jessica Rich, Director of the FTC’s Bureau of Consumer Protection. “But Lumosity simply did not have the science to back up its ads.”

In the 26 page complaint filed by the FTC in the US District Court in San Francisco the FTC details the claims made by the Luminosity program which consists of 40 games that target specific areas of the brain. Ads for the program claimed that subscribers who played for 10-15 minutes three or four times a week would “reach their full potential in every aspect of life.” The company sold both online and mobile app options of the program. Fees ranged from a monthly subscription price of $14.95 to lifetime memberships which went for $299.95.

Lumos Labs marketed the program through emails, blog posts and social media, as well at television ads and infomercials. Using Google AdWords they purchased hundreds of keywords related to memory, Alzheimer’s and dementia so that when Internet users searched for information on those topics, they would be led to the Luminosity.com website

The FTC alleged in their suit that the defendants claimed training with Lumosity would 1) improve performance on everyday tasks, in school, at work, and in athletics; 2) delay age-related cognitive decline and protect against mild cognitive impairment, dementia, and Alzheimer’s disease; and 3) reduce cognitive impairment associated with health conditions, including stroke, traumatic brain injury, PTSD, ADHD, the side effects of chemotherapy, and Turner syndrome, and that scientific studies proved these benefits. The company was also charged with failing to disclose that their testimonials from users had been solicited through a contest that promised prizes like an iPad and lifetime access to the Luminosity program.

Under Federal law, any product that claims to treat or prevent any serious illness must be submitted to the Food and Drug Administration for testing and approval. To date, the FDA has not approved a single brain training program as a treatment or preventative for any illness. The order also imposed a $50 million judgment against Lumos Labs, which was suspended because of the financial condition of the company after the $2 million payment of fines.

The video below discusses the charges against Lumos Labs and why the FTC took action. Take a look to learn more about this issue and brain training games.
 
About the Author
English
I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
MAY 31, 2022
Neuroscience
How Visual Maps are Generated in the Brain
MAY 31, 2022
How Visual Maps are Generated in the Brain
Different parts of the brain have been carefully mapped, so we have some idea of what parts of the brain are used to per ...
JUN 07, 2022
Chemistry & Physics
This Day in Science History 6/7/1954: Death of Alan Turing, Father of Theoretical Computer Science and Artificial Intelligence.
JUN 07, 2022
This Day in Science History 6/7/1954: Death of Alan Turing, Father of Theoretical Computer Science and Artificial Intelligence.
Alan Turing, a British mathematical genius, was born in Paddington, London on June 23, 1912. His father was a civil serv ...
JUN 10, 2022
Immunology
Is Autoimmunity Related to Schizophrenia?
JUN 10, 2022
Is Autoimmunity Related to Schizophrenia?
Schizophrenia is estimated to impact around 24 million people, which is about 1 in 300 people worldwide. This poorly und ...
JUN 13, 2022
Technology
A 'Goldilocks amount' of time sent online could be good for teenagers' wellbeing
JUN 13, 2022
A 'Goldilocks amount' of time sent online could be good for teenagers' wellbeing
We live in an age where everyone is online, but moderation is key to a healthy life. We all love being online, but we al ...
JUN 15, 2022
Cell & Molecular Biology
Membraneless Organelles are Linked to Alzheimer's
JUN 15, 2022
Membraneless Organelles are Linked to Alzheimer's
In recent years, scientists have found that some liquids inside of cells behave like oil and vinegar do - droplets of li ...
JUL 14, 2022
Cannabis Sciences
Why Does Weed Smell?
JUL 14, 2022
Why Does Weed Smell?
What is behind the aroma of cannabis? Here's the science involved in why weed smells the way it does.
Loading Comments...